Neurotransmitter effects in human immunodeficiency virus (HIV) and simian immuno-deficiency virus (SIV) infection

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 8, Issue 2, 2009, Pages 153-163

  Neuen Jacob, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Brain; Dementia; Excitatory amino acid transporters; Glutamate; HIV; Memantine; SIV

Indexed keywords

APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; LEVODOPA; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; SELEGILINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS; VIRUS IMMUNITY;

EID: 73449114230     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152309789152093     Document Type: Article

References (66)

1. McArthur, J.C. HIV dementia: an evolving disease. J. Neuroimmunol., 2004, 157, 3-10.
2. Cysique, L.A.; Maruff, P; Brew, B.J. Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 2006, 66, 1447-1450.
3. Kaul, M.; Garden, G.A.; Lipton, S.A. Pathways to neuronal injury ans apoptosis in HIV-associated dementia. Nature, 2001, 410, 988-994.
4. Gras, G.; Chrétien, F.; Vallat-Decouvelaere, A.V.; Le Pavec, G.; Porcheray, F.; Bossuet, C.; Léone, C.; Mialocq, P.; Dereuddre-Bosquet, N.; Clayette, P.; Le Grand, R.; Créminon, C.; Dormont, D.; Rimaniol, A.C.; Gray, F. Regulated expression of sodiumdependant glutamate transporterts and sythetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol., 2003, 13, 211-222.
5. Porcheray, F.; Léone, C.; Samah, B.; Rimaniol, A.C.; Dereuddre-Bosquet, N.; Gras, G. Glutamate metabolism in HIV-infected macrophages: implications for the CNS. Am. J. Physiol. Cell Physiol., 2006, 291, C618-626.
6. Vallat-Decouvelaere, A.V.; Chrétien, F.; Gras, G.; Le Pavec, G.; Dormont, D.; Gray, F. Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients: a neuroprotective role for activated microglia? J. Neuropathol. Exp. Neurol.; 2003, 62, 475-485.
7. Lipton, S.A.; Sucher, N.J.; Kaiser, P.K.; Dreyer, E.B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron, 1991, 7, 111-118.
8. Wang, P.; Barks, J.D.; Silverstein, F.S. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Neuroscience, 1999, 88, 585-597.
9. Haughey, N.J.; Nath, A.; Mattson, M.P.; Slevin, J.T.; Geiger, J.D. HIV-1 tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem., 2001, 78, 457-467.
10. Heyes, M.P.; Ellis, R.J.; Ryan, L.; Childers, M.E.; Grant, I.; Wolfson, T.; Archibald, S.; Jernigan, T.L.; H.N.R.C. Group; HIV Neurobehavioural Research Center. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain, 2001, 124, 1033-1042.
11. Koutsilieri, E.; Sopper, S.; Heinemann, T.; Scheller, C.; Lan, J.; Stahl-Nennig, C.; ter Meulen, V.; Riederer, P.; Gerlach, M. Involvement of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta). AIDS Res. Hum. Retroviruses, 1999, 15, 471-477.
12. Bossuet, C.; Vaufrey, F.; Condé, F.; Chrétien, F.; Pichon, J.; Hantreye, P.; Le Grand, R.; Dormont, D.; Gras, G. Up-regulation of glutamate concentration in the putamen and in the prefrontal cortex of asymptomatic SIVmac251-infected macaques without major brain involvement. J. Neurochem., 2004, 88, 928-938.
13. Tong, G.; Jahr, C.E. Block of glutamate transporters potentiates postsynaptic excitation. Neuron, 1994, 13, 1195-1203.
14. ++-dependant glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA, 1992, 89, 10955-10959.
15. Shahidharan, P.; Plaitakis, A. Cloning and characterization of a glutamate transporter cDNA from human cerebellum. Biochem. Biophys. Acta, 1993, 1216, 161-164.
16. Shahidharan, P.; Wittenberg, I.; Plaitakis, A. Molecular cloning of human brain glutamate/aspartate transporter II. Biochem. Biophys. Acta, 1994, 1191, 393-396.
17. Kirschner, M.A.; Copeland, N.G.; Gilbert, D.J.; Jenkins, N.A.; Amara, S.G. Mouse excitatory amino acid transporter EAAT2: isolation, characterization, and proximity to neuroexcitability loci on mouse chromosome 2. Genomics, 1994, 24, 218-224.
18. Kanai, Y.; Hediger, M.A. Primary structure and functional characterization of high-affinity glutamate transporter. Nature, 1992, 360, 467-471.
19. Furuta, A.; Martin, L.J.; Lin, C.L.; Dykes-Hoberg, M.; Rothstein, J.D. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporters 3 and 4. Neuroscience, 1997, 81, 1031-1042.
20. Maragakis, N.J.; Dykes-Hoberg, M.; Rothstein, J.D. Altered expression of he glutamate transporter EAAT2b in neurological disease. Ann. Neurol., 2004, 55, 469-477.
21. Jacob, C.P.; Koutsilieri, E.; Bartl, J.; Neuen-Jacob, E.; Arzberger, T.; Zander, N.; Ravid, R.; Roggendorf, W.; Riederer, P.; Grünblatt, E. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J. Alzheimers Dis., 2007, 11, 97-116
22. Neuen-Jacob, E.; Kuckert, S.; Arendt, G. Dysregulation of the glutamatergic system plays an important role in the pathogenesis of HIV dementia. Acta Neuropathol. (Berlin), 2001, 102, 535.
23. Chrétien, F.; Vallat-Decouvelaere, A.V.; Bossuet, C.; Rimaniol, A.C.; Le Grand, R.; Le Pavec, G.; Créminon, C.; Dormont, D.; Gray, F.; Gras, G. Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques. Neuropathol. Appl. Neurobiol., 2002, 28, 410-417.
24. Mattson, M.P.; Haughey, N.J.; Nath, A. Cell death in HIV dementia. Cell Death Differ., 2005, 12 (Suppl. 1), 893-904.
25. Johnson, J.W.; Kotermanski, S.E. Mechanism of action of memantine. Curr. Opin. Pharmacol., 2006, 6, 61-67.
26. Lipton, S.A. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology, 1992, 42, 1403-1405.
27. Nath, A.; Haughey, N.J.; Jones, M.; Anderson, C.; Bell, E.J.; Geiger, J.D. Synergistic neuronotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol., 2000, 47, 186-194.
28. Toggas, S.M.; Masliah, E.; Mucke, L. Prevention of HIV-1 pg120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res., 1996, 706, 303-307.
29. Anderson, E.R.; Gendelman, H.E.; Xiong, H. Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis. J. Neurosci., 2004, 24, 7194-7198.
30. Jenuwein, M.; Scheller, C.; Neuen-Jacob, E.; Sopper, S.; Tatschner, T.; ter Meulen, V.; Riederer, P.; Koutsilieri, E. Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys. J. Neurovirol., 2004, 10, 163-170.
31. Scheller, C.; Sopper, S.; Jenuwein, M.; Neuen-Jacob, E.; Tatschner, T.; Grünblatt, E.; ter Meulen, V.; Riederer, P.; Koutsilieri, E. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J. Neurochem., 2005, 95, 377-387.
32. Meisner, F.; Neuen-Jacob, E.; Sopper, S.; Schmidt, M.; Schlammes, S.; Scheller, C.; Vosswinkel, D.; ter Meulen, V.; Riederer, P.; Koutsilieri, E. Disruption of excitatory amino acid transporters in brains of SIV-infected rhesus macaques is associated with microglia activation. J. Neurochem., 2008, 104, 202-209.
33. Meisner, F.; Scheller, C.; Kneitz, S.; Sopper, S.; Neuen-Jacob, E.; Riederer, P.; ter Meulen, V.; Koutsilieri, E. German Competence Network HIV/AIDS. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infetced macaques: a novel pharmacological action of memantine. Neuropsychopharmacology, 2008, 33, 2228-2236.
34. Sopper, S.; Demuth, M.; Stahl-Hennig, C.; Hunsmann, G.; Plesker, R.; Coulibaly, C.; Czub, S.; Ceska, M.; Koutsilieri, E.; Riederer, P.; Brinkmann, R.; Katz, M.; ter Meulen, V. The effect of simian imunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology, 1996, 220, 320-329.
35. Sopper, S.; Sauer, U.; Müller, J.G.; Stahl-Hennig, C.; ter Meulen, V. Early activation and proliferation of T cells in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res. Hum. Retroviruses, 2000, 16, 689-697.
36. Lipton, S.A. HIV-related injury: Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol. Neurobiol., 1994, 8, 181-186.
37. Piani, D.; Frei, K.; Do, K.Q., Cuénod, M.; Fontane, A. Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci. Lett., 1991, 133, 159-162.
38. Xing, H.Q.; Hayakawa, H.; Gelpi, E.; Kubota, R.; Budka, H.; Izimo, S. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. J. Neuropathol. Exp. Neurol. , 2009, 68(2), 199-209.
39. Meldrum, B.S.; Akbar, M.T.; Chapman, A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res., 1999, 36, 189-204.
40. Thai, D.R. Exitatory amino acid transporter EAAT-2 in tangle-bearing nurons in Alzheimer's disease. Brain Pathol., 2002, 12, 405-411.
41. Wesselingh, S.L.; Power, C.; Glass, J.D.; Tyor, W.R.; McArthur, J.C.; Farber, J.M.; Griffin, J.W.; Griffin, D.E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol., 1993, 33, 576-582.
42. Kort, J.J. Impairment of excitatory amino acid transport in astroglial cells infected with the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses, 1998, 14, 1329-1339.
43. Sitcheran, R.; Gupta, P.; Fisher, P. B. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNF-alpha-controlled repression. EMBO J., 2005, 24, 510-520.
44. Berger, J.R.; Arendt, G. HIV dementia: the role of the basal ganglia and dopaminergic system. J. Psychopharmacol., 2000, 14, 214-221.
45. Koutsilieri, E.; Sopper, S.; Scheller, C.; ter Meulen, V.; Riederer, P. Parkinsonsm in HIV dementia. J. Neural. Transm., 2002, 109, 767-775.
46. Itoh, K.; Mehrain, P.; Weis, S. Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta Neuropath. (Berlin), 2000, 99, 376-384.
47. Theodore, S.; Cass, W.A..; Maragos, W.F. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience, 2006, 137, 925-935.
48. Wallace, D.R.; Dodson, S.; Nath, A.; Booze, R.M. Estrogen attenuates gp120- and tat1-72-incued oxidative stress and prevents loss of dopamine transporter function. Synapse, 2006, 59, 51-60.
49. Roberts, E.S.; Burudi, E.M.; Flynn, C.; Madden, L.J.; Roinick, K.L.; Watry, D.D.; Zandonatti, M.A.; Taffe, M.A.; Fox, H.S. Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression pattern throughout disease progression and impact on neuro AIDS. J. Neuroimmunol., 2004, 157, 81-92.
50. Quack, G.; Hesselink, M.; Dnysz, W.; Spanagel, R. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover. J. Neural. Transm. Suppl., 1995, 46, 97-105.
51. Hesselink, M.B.; De Boer, A.G.; Breimer, D.D.; Danysz, W. Dopamine relase in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: a microdialysis study in rats. J. Neural. Transm., 1999, 106, 803-818.
52. Spannagel, R.; Eilbacher, B.; Wilke, R. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur. J. Pharmacol., 1994, 262, 21-26.
53. Clement, H.W.; Grote, C.; Svensson, L.; Engel, J.; Zöfel, P.; Wesemann, W. In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat. J. Neurol. Transm. Suppl., 1995, 46, 107-115.
54. Fowler, C.J.; Benedetti, M.S. The metabolism of dopamine by both forms of monamine oxidase in the rat brain and its inhibition by cimoxatone. J. Neurochem., 1983, 40, 1534-1541.
55. Glover, V.; Sandler, M.; Owen, F.; Riley, G.J. Dopamine is a monoamine oxidase B substrate in man. Nature, 1977, 265, 80-81.
56. Koutsilieri, E.; Scheller, C.; Czub, S.; Sopper, S.; ter Meulen, V.; Riederer, M. Dopamine is a pathogenic factor in HIV-induced Neuro-AIDS. In: Nagatsu, T.; Nabeshima, T.; McCarty, R.; Goldstein, D.S., Eds. Catecholamine Research: From Molecular Insights to Clinical Medicine. Kluwer Academic/Plenum Publishers: New York, Boston, Dordrecht, London, Moscow; Adv. Behav. Biol., 2002, 53, 475-478.
57. Czub, S.; Czub, M.; Kousilieri, M.; Sopper, S.; Villinger, F.; Müller, J.G.; Stahl-Hennig, C.; Riederer, P.; ter Meulen, V.; Gostonyi, G. Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol., 2004, 107, 216-226.
58. Czub, S.; Koutsilieri, E.; Sopper, S.; Czub, M.; Stahl-Hennig, C.; Müller, J.G.; Pedersen, V.; Gsell, W.; Heeney, J.L.; Gerlach, M.; Gosztonyi, G.; Riederer, P.; ter Meulen, V. Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol., 2001, 101, 85-91.
59. Guillin, O.; Griffon, N.; Bezard, E.; Leriche, L.; Diaz, J.; Gross, C.; Sokoloff, P. Brain-derived neurotrophic factor controls dopamine D3 recptor expression: therapeutic implication in Parkinson's disease. Eur. J. Pharmacol., 2003, 480, 89-95.
60. Albrecht, D.; Garcia, L.; Cartier, L.; Kettlun, A.M.; Vergara, C.; Collados, L.; Trophic factors in cerebrospnal fluid and spinal cord of patients with tropical spastic paraparesis, HIV, and Creutzfeldt-Jakob disease. AIDS Res. Hum. Retroviruses, 2006, 22, 248-254.
61. Sawada, M.; Imamura, K.; Nagatsu, T. Role of cytokines in inflammatory process in Parkinson's disease. J. Neural. Transm. Suppl., 2006, 70, 373-381.
62. Schifitto, G.; Navia, B.A.; Yiannoutsos, C.T.; Marra, C.M.; Chang, L.; Ernst, T.; Jarvik, J.G.; Miller, E.N.; Singer, E.J.; Ellis, R.J.; Kolson, D.L.; Simpson, D.; Nath, A.; Berger, J.; Shriver, S.L.; Millar, L.L.; Colquhoun, D.; Lenkinski, R.; Gonzalez, R.G.; Lipton, S.A.; Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; and the HIV MRS Consortium. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS, 2007, 21, 1877-1886.
63. Kornhuber, J.; Mack-Burkhardt, F.; Riederer, P., Hebenstreit, G.F.; Reynolds, G.P.; Andrews, H.B. [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J. Neural. Transm., 1989, 77, 231-236.
64. Danysz, W.; Parsons, C.G. The NMDA receptor antagonist memantine as a symptomatolgical and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int. J. Geriatr. Psychiatry, 2003, 18, S23-S32.
65. Ramirez, S.H.; Sanchez, F.J.; Dimitri, C.A.; Gelbard, H.A.; Dewhurst, S.; Maggirwr, S.B. Neurotrophins prevent HIV Tat-induced neuronal apoptosis via a nuclear factor-kappaB (NF-kappaB)-dependant mechanism. J. Neurochem., 2001, 78, 874-889.
66. Koutsilieri, E.; Sopper, S.; Scheller, C.; ter Meulen, V.; Riederer, P. Involvement of dopamine in the progression of AIDS dementia complex. J. Neural. Transm., 2002, 109, 399-410.